Danaher Corporation DHR
Set alert
At close · Oct 30
After hours · Oct 30, 5:41 PM ET
- YTD
- +1.45%
- 1 year
- +7.99%
- Open
- 238.46
- Prev close
- 236.98
- Mkt cap
- 163.25B
- Vol
- 3.75M
- Avg vol
- 4.03M
- EPS
- 6.04
- P/E
- 38.45
- Div yield
- 0.68%
More statistics
- Low
- 230.46
- High
- 238.38
- Forward P/E
- 24.93
- Beta
- 0.80
- Short ratio
- 1.76
- Inst. own
- 83.68%
- Dividend
- 1.60
- Ex-div date
- Sep 29, 2026
- Earnings
- Jan 27, 2027
- 50-d avg
- 218.53
- 200-d avg
- 201.14
- 1y target
- 259.90
5D chart
Signals (152)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:20 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:10 PM | 2 days ago |
| SMA: Bullish | Oct 30, 3:05 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:55 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:55 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:50 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:50 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:45 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 2:45 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:15 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:30 PM | 2 days ago |
| SMA: Bearish | Oct 30, 1:25 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:20 PM | 2 days ago |
| SMA: Bullish | Oct 30, 1:15 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:50 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:45 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:35 PM | 2 days ago |
| SMA: Bullish | Oct 30, 12:15 PM | 2 days ago |
| SMA: Bearish | Oct 30, 11:55 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:45 AM | 2 days ago |
| SMA: Bearish | Oct 30, 11:40 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 11:35 AM | 2 days ago |
| SMA: Bullish | Oct 30, 11:30 AM | 2 days ago |
| RSI: Oversold | Oct 30, 11:05 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:40 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:40 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 9:40 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:35 AM | 2 days ago |
| SMA: Bullish | Oct 30, 9:35 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bullish | Oct 29, 3:25 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:40 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:30 PM | 3 days ago |
| RSI: Oversold | Oct 29, 2:15 PM | 3 days ago |
| RSI: Oversold | Oct 29, 1:50 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:15 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:15 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:55 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:45 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:40 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:25 PM | 3 days ago |
| SMA: Bullish | Oct 29, 12:20 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:15 PM | 3 days ago |
| SMA: Bearish | Oct 29, 10:25 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:10 AM | 3 days ago |
| SMA: Bullish | Oct 29, 10:10 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 3 days ago |
| SMA: Bearish | Oct 29, 10:05 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:45 AM | 3 days ago |
| SMA: Bullish | Oct 29, 9:40 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 9:40 AM | 3 days ago |
| SMA: Bearish | Oct 28, 3:50 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:50 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:45 PM | 4 days ago |
| SMA: Bullish | Oct 28, 3:30 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:50 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:45 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:35 PM | 4 days ago |
| SMA: Bullish | Oct 28, 2:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:20 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:30 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:25 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 1:15 PM | 4 days ago |
| SMA: Bullish | Oct 28, 1:10 PM | 4 days ago |
| SMA: Bearish | Oct 28, 1:00 PM | 4 days ago |
| SMA: Bullish | Oct 28, 12:50 PM | 4 days ago |
| SMA: Bearish | Oct 28, 11:30 AM | 4 days ago |
| SMA: Bearish | Oct 28, 11:00 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:45 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:45 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:40 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:35 AM | 4 days ago |
| SMA: Bearish | Oct 28, 10:25 AM | 4 days ago |
| RSI: Overbought | Oct 28, 10:00 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 4 days ago |
| RSI: Overbought | Oct 28, 9:30 AM | 4 days ago |
| SMA: Bearish | Oct 27, 3:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:10 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 3:10 PM | 5 days ago |
| SMA: Bullish | Oct 27, 2:55 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:20 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 2:00 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:40 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:40 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:40 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 1:30 PM | 5 days ago |
| SMA: Bearish | Oct 27, 1:25 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:15 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:25 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:20 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:10 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:10 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:05 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:05 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:00 PM | 5 days ago |
| SMA: Bearish | Oct 27, 11:25 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:25 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:15 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:10 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:00 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:30 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:30 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:15 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:15 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 10:15 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:05 AM | 5 days ago |
| SMA: Bullish | Oct 27, 10:05 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:00 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:00 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 9:55 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:50 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:50 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:40 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 3:40 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 3:05 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:55 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:55 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:50 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:45 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:35 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:35 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:25 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:20 PM | 6 days ago |
| SMA: Bullish | Oct 26, 2:15 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:05 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:00 PM | 6 days ago |
| SMA: Bearish | Oct 26, 2:00 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:50 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:50 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:50 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 1:45 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:40 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:35 PM | 6 days ago |
| SMA: Bearish | Oct 26, 1:30 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:15 PM | 6 days ago |
| SMA: Bullish | Oct 26, 1:10 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:55 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:40 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:30 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:15 PM | 6 days ago |
| SMA: Bearish | Oct 26, 11:20 AM | 6 days ago |
| SMA: Bullish | Oct 26, 11:10 AM | 6 days ago |
| SMA: Bearish | Oct 26, 11:05 AM | 6 days ago |
News
3 days ago benzinga.com
Bill Ackman’s 20-Year Investing Rule Puts These Cash-Flow and Moat ETFs in Focus
Bill Ackman’s 20-year investing rule puts cash flow and competitive advantages in focus. See how COWZ and MOAT ETFs stack up amid AI spending fears.
5 days ago zacks.com
Danaher (DHR) Upgraded to Buy: Here's Why
Danaher (DHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
6 days ago benzinga.com
Billionaire Investor Adds to Danaher Stake After Cutting It Earlier This Year
Dan Loeb’s Third Point increased its Danaher stake to 540,000 shares in the second quarter, up from 525,000, with a $102.8 million valuation.
1 week ago defenseworld.net
Danaher Corporation $DHR Shares Sold by Compass Wealth Management LLC
Compass Wealth Management LLC reduced its holdings in shares of Danaher Corporation (NYSE: DHR) by 9.2% during the third quarter, according to its most recent disclosure with the Securities and…
1 week ago defenseworld.net
Danaher Corporation $DHR Shares Newly Acquired by Cantor Fitzgerald Investment Advisors L.P.
Cantor Fitzgerald Investment Advisors L.P. bought a new stake in shares of Danaher Corporation (NYSE: DHR) in the third quarter, according to its most recent disclosure with the Securities and…
1 week ago benzinga.com
Danaher Posts First Earnings Under New CEO; Emphasizes Need For Improved Execution, Innovation
Danaher shares fell despite upbeat Q3 results. TD Cowen raised its target, citing tariffs and a cautious 2027 outlook.
-
1 week ago benzinga.com
Citigroup Maintains Buy on Danaher, Raises Price Target to $270
Citigroup analyst Patrick Donnelly maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $230 to $270.
1 week ago benzinga.com
Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings
Danaher beat Q3 earnings and revenue estimates, raised FY2026 profit guidance, and analysts lifted price targets despite shares falling 1.8%.
1 week ago zacks.com
LH vs. DHR: Which Stock Is the Better Value Option?
Investors interested in Medical Services stocks are likely familiar with Labcorp Holdings (LH) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
-
1 week ago benzinga.com
Barclays Maintains Overweight on Danaher, Raises Price Target to $260
Barclays analyst Luke Sergott maintains Danaher (NYSE:DHR) with a Overweight and raises the price target from $255 to $260.
-
1 week ago benzinga.com
JP Morgan Maintains Overweight on Danaher, Raises Price Target to $270
JP Morgan analyst Casey Woodring maintains Danaher (NYSE:DHR) with a Overweight and raises the price target from $250 to $270.
-
1 week ago benzinga.com
TD Cowen Maintains Buy on Danaher, Raises Price Target to $270
TD Cowen analyst Dan Brennan maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $255 to $270.
-
1 week ago benzinga.com
Stifel Maintains Buy on Danaher, Raises Price Target to $260
Stifel analyst Daniel Arias maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $220 to $260.
-
1 week ago benzinga.com
Baird Maintains Outperform on Danaher, Raises Price Target to $254
Baird analyst Catherine Schulte maintains Danaher (NYSE:DHR) with a Outperform and raises the price target from $246 to $254.
1 week ago seekingalpha.com
Danaher Q3 Recap: Decent Results, Still A Hold
Danaher Corporation is rated hold, as the stock trades at a small premium and offers an 8.85% expected return, below my threshold. Q3 earnings showed solid performance: revenue up 8.3% YoY to $6.55B,…
1 week ago fool.com
Why Danaher Stock Bounced Higher Today
It beat analyst estimates for both revenue and profitability. Its full-year earnings guidance also topped the pundit consensus.
1 week ago seekingalpha.com
Danaher Corporation (DHR) Q3 2026 Earnings Call Transcript
Danaher Corporation ( DHR ) Q3 2026 Earnings Call October 21, 2026 8:00 AM EDT Company Participants Rachel Vatnsdal Olson - Vice President of Investor Relations Julie Montgomery - President, CEO &…
1 week ago fool.com
Danaher: 3 Key Takeaways for Long-Term Investors
Danaher raised full-year earnings per share guidance to $8.57 to $8.62. Biotechnology orders grew mid-teens during the third quarter.
1 week ago gurufocus.com
Danaher Corp (DHR) (Q3 2026) Earnings Call Highlights: Core Growth Accelerates to 5.5% Ex-Respiratory as EPS Guidance Rises
Revenue: Q3 2026 sales of $6.6 billion.Core Revenue Growth: Up 3% overall; up 5.5% excluding respiratory revenue (100 bps acceleration from Q2).Respiratory Reve
1 week ago seekingalpha.com
Danaher Q3 Review: Interested To See What The New Management Will Bring
Danaher Corporation delivered mixed Q3 results, with revenue up 8.3% y/y but growth driven mainly by acquisitions and tariff refunds. Adjusted operating margin reached 29%, exceeding guidance, yet…
1 week ago zacks.com
DHR Q3 Earnings Beat on Biotechnology Strength, Sales in Line
Danaher's third-quarter earnings beat estimates by 9.9%, driven by stronger Biotechnology profitability, while it raised its 2026 adjusted earnings outlook.
1 week ago benzinga.com
Danaher Beats Profit Estimates, Raises Outlook as Customer Demand Improves
Danaher Corp. (NYSE:DHR) on Wednesday reported third-quarter adjusted earnings of $2.11 per share, beating the analyst consensus estimate of $1.92.
1 week ago benzinga.com
Danaher Beats Profit Estimates, Raises Outlook as Customer Demand Improves
Danaher topped Q3 earnings estimates at $2.11 per share on $6.55 billion revenue, raising its full-year 2026 adjusted EPS outlook on steady biopharma demand.
1 week ago marketbeat.com
Danaher Q3 Earnings Call Highlights
Danaher NYSE: DHR reported third-quarter 2026 results that exceeded its expectations, citing improved market conditions, commercial execution and operational performance across its Biotechnology,…
1 week ago benzinga.com
Meta, Tesla On Deck Wednesday As AI Spending, Auto Demand Face Test
Meta Platforms and Tesla headline Wednesday’s reports, with investors focused on whether AI investment can keep driving growth while Tesla’s core auto business weakens. Philip Morris International,…
1 week ago zacks.com
Danaher (DHR) Reports Q3 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Danaher (DHR) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall…
1 week ago benzinga.com
Danaher Q3 2026 Earnings Call Transcript
Danaher (NYSE:DHR) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
1 week ago zacks.com
Danaher (DHR) Tops Q3 Earnings and Revenue Estimates
Danaher (DHR) came out with quarterly earnings of $2.11 per share, beating the Zacks Consensus Estimate of $1.92 per share. This compares to earnings of $1.89 per share a year ago.
-
1 week ago benzinga.com
Danaher Sees Q4 2026 Non-GAAP Core Revenue Excluding Respiratory Revenue Up 4%-5% YoY
Danaher (NYSE:DHR) expects fourth quarter of 2026 non-GAAP core revenue, excluding respiratory revenue, to increase 4.0% to 5.0% year-over-year.
1 week ago prnewswire.com
Danaher Reports Third Quarter 2026 Results
WASHINGTON, Oct. 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the third quarter 2026. All results in this release reflect only continuing operations and…
1 week ago defenseworld.net
Danaher Corporation $DHR Stock Holdings Lowered by Louisbourg Investments Inc.
Louisbourg Investments Inc. lessened its stake in Danaher Corporation (NYSE: DHR) by 23.6% in the third quarter, according to the company in its most recent disclosure with the Securities and…
1 week ago benzinga.com
Meta Platforms, Tesla Could Swing More Than $100 Billion After Earnings
Discover 9 stocks to watch ahead of Wednesday’s earnings, including Meta, Tesla and Lam Research, with options-implied moves reaching 7.42%.
1 week ago benzinga.com
9 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
1 week ago benzinga.com
Danaher Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Danaher Corporation (NYSE:DHR) will release earnings for its third quarter before the opening bell on Wednesday, Oct. 21.
1 week ago benzinga.com
Danaher Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Danaher will report Q3 earnings Oct. 21, with estimates of $1.92 EPS and $6.56B revenue; shares fell 1.1% despite bullish analyst targets.
1 week ago defenseworld.net
Danaher Corporation $DHR Stock Bought by SteelPeak Wealth LLC
SteelPeak Wealth LLC increased its holdings in Danaher Corporation (NYSE: DHR) by 239.4% during the undefined quarter, according to the company in its most recent disclosure with the Securities and…
1 week ago defenseworld.net
Danaher Corporation $DHR Stock: IFP Advisors Inc Increases Stake
IFP Advisors Inc lifted its holdings in shares of Danaher Corporation (NYSE: DHR) by 1,000.9% in the third quarter, according to the company in its most recent disclosure with the Securities and…
2 weeks ago benzinga.com
Lam Research Could Swing $28.6 Billion After Earnings
Discover 9 stocks with the biggest options-implied earnings moves, led by Spotify at 9.31%, as investors prepare for key quarterly results.
2 weeks ago benzinga.com
Danaher Brings NVIDIA AI Into Scientific Instruments in Push for Faster Discoveries
Danaher shares rose premarket after announcing an AI partnership with NVIDIA. DHR reports Q3 earnings Oct. 21.
2 weeks ago benzinga.com
What's Going On With NVIDIA Stock Wednesday?
NVIDIA edges higher in premarket trading as technical levels hold. Key support, resistance, and stock analysis updated for NVDA.
-
2 weeks ago benzinga.com
Morgan Stanley Maintains Overweight on Danaher, Raises Price Target to $240
Morgan Stanley analyst Kallum Titchmarsh maintains Danaher (NYSE:DHR) with a Overweight and raises the price target from $220 to $240.
-
2 weeks ago benzinga.com
TD Cowen Maintains Buy on Danaher, Raises Price Target to $255
TD Cowen analyst Dan Brennan maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $236 to $255.
3 weeks ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
-
3 weeks ago benzinga.com
Barclays Maintains Overweight on Danaher, Raises Price Target to $255
Barclays analyst Luke Sergott maintains Danaher (NYSE:DHR) with a Overweight and raises the price target from $230 to $255.
-
3 weeks ago benzinga.com
Danaher To Launch Its First AI-powered Autonomous Lab To Help Researchers Develop Custom Antibodies And Other Molecular Tools Faster And More Efficiently; Expected To Operate At Scale In Early 2027
The lab will combine artificial intelligence, robotics and technologies from several Danaher operating companies in one connected workflow. It is the first step in a broader Danaher initiative to…
-
3 weeks ago benzinga.com
RBC Capital Maintains Outperform on Danaher, Raises Price Target to $250
RBC Capital analyst Dan Leonard maintains Danaher (NYSE:DHR) with a Outperform and raises the price target from $215 to $250.
-
1 month ago benzinga.com
Guggenheim Maintains Buy on Danaher, Raises Price Target to $250
Guggenheim analyst Subbu Nambi maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $200 to $250.
-
1 month ago benzinga.com
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
2 months ago benzinga.com
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
-
3 months ago benzinga.com
Danaher Appoints Julie Sawyer Montgomery As President, CEO, Effective Oct. 1, Succeeding Rainer Blair
Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") announced that the Company's Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a